A comparative study of scoring systems that accurately predict the prognosis of lower gastrointestinal bleeding

Author:

Yeon Sang Hoon1,Moon Hee Seok1,Choi Seong Woo1,Kang Sun Hyung1,Sung Jae Kyu1,Jeong Hyun Yong1

Affiliation:

1. Chungnam National University Hospital, Chungnam National University School of Medicine

Abstract

Abstract Purpose Lower gastrointestinal bleeding (LGIB) can be fatal; therefore, several scoring systems have been developed to predict its prognosis. We aimed to compare the mortality predictions and evaluate the usefulness of various scoring systems. Methods The medical records of 3,794 patients who visited the emergency department with hematochezia between January 2016 and December 2021 were retrospectively reviewed. We calculated the areas under the receiver operating characteristic curves (AUROCs) for 30-day mortality and prolonged hospital stay (≥ 10 days), based on the age, blood tests, and comorbidities (ABC); AIMS65; Glasgow Blatchford; Oakland; Rockall (pre-endoscopy); and SHA2PE scores. We compared the predictive accuracy of each score. Results Data for 963 patients (median age, 69 years; males, 54.5%; median hospital stay, 6 days) with colonoscopy-confirmed LGIB were analyzed. The 30-day mortality rate was 3.5%. The most common causes of LGIB were ischemic colitis and diverticulum hemorrhage in 19.3% and 19.2% of the cases, respectively. The AIMS65 (AUROC, 0.845) and ABC (AUROC, 0.835) scores were superior in predicting 30-day mortality (both p < 0.001). The SHA2PE score was the most accurate predictor of prolonged hospital stay (AUROC, 0.728; p < 0.001). Through multivariate regression analysis, 30-day mortality was correlated with albumin level ≤ 3.0 g/dL, international normalized ratio > 1.5, blood urea nitrogen level ≥ 30 mg/dL, and systolic blood pressure (SBP) < 100 mmHg. Prolonged hospital stay was correlated with liver cirrhosis, hemoglobin ≤ 10 g/dL, albumin level ≤ 3.0 g/dL, and SBP < 100 mmHg. Conclusion The recently developed scoring systems accurately predict LGIB prognosis, and their usefulness in clinical decision-making was confirmed.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3